COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04306393


Column Value
Trial registration number NCT04306393
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : May 27, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

Lorenzo Berra, MD

Contact
Last imported at : May 27, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

lberra@mgh.harvard.edu

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-03-12

Recruitment status
Last imported at : June 23, 2022, 8:30 p.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

inclusion criteria: (1) adult patients, >/= 18 year-old; (2) patients admitted to the icu; (3) patients who are intubated and mechanically ventilated; (4) confirmed diagnosis of sars-cov2 by positive rt-pcr.

Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

(1) patients intubated for more than 72 hours from initiation of the treatment gas; (2) subjects enrolled in another interventional research study; (3) physician of record opposed to enrolling the patient due to perceived safety concerns; or any condition that does not allow the protocol to be followed safely; (4) subjects with past medical history of lung malignancy or pneumonectomy or lung transplant; (5) subjects receiving a tidal volume < 3 cc/kg of ideal body weight at the time of enrollment; (6) subjects with severe burns involving more than 40% of total body surface area; (7) subjects that have experienced cardiac arrest with cpr for longer than 30 minutes; (8) subjects with a presumed severe deficit in cerebral function with fixed dilated pupil; (9) subjects receiving renal replacement therapy at the time of enrollment; (10) subjects who have an impaired ability to ventilate without assistance; (11) subjects who have a history of malignancy or other irreversible disease/conditions with a 6-month mortality > 50%; (12) subjects not fully committed to full support at the time of enrollment; (13) subject receiving inhaled nitric oxide gas prior to enrollment; (14) subject's hospital admission unrelated to covid-19.

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Massachusetts General Hospital

Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

99

Countries
Last imported at : May 27, 2021, 12:32 a.m.
Source : ClinicalTrials.gov

Sweden;United States

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Severe disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

6: Severe disease at enrollment

Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

200

primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Change of arterial oxygenation at 48 hours from enrollment

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 2

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 890, "treatment_name": "Nitric oxide gas", "treatment_type": "Gas inhalation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]